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Abstract
Sepsis is still one of the leading causes of child mortality worldwide, despite advances in its diagnosis and treatment. 
Difficulties in recognizing the transition of a localized infectious-inflammatory process to a generalized one lead to a 
belated diagnosis and the beginning of therapy. Meanwhile, the earlier treatment is started, the higher the patients’ 
chances of life. Early diagnosis of sepsis, which corresponds to modern ideas about this condition, is one of the 
main tasks for both scientists and practitioners. The aim of this review is to study modern recommendations for the 
diagnosis of sepsis and septic shock in children. The article reflects the epidemiology, etiological features, modern 
definitions, and methods of diagnosis of pediatric sepsis.
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Introduction
Sepsis is one of the leading causes of child 
mortality worldwide, despite the progress made 
in its study over the past decades [1], [2]. In 2017, 
the World Health Organization named sepsis as 
one of the priority tasks of healthcare in the coming 
decade [3], [4]. Clinically, sepsis is a syndrome that 
complicates the course of severe out-of-hospital 
and in-hospital infections and leads, in turn, to life-
threatening conditions such as septic shock and 
multiple organ failure [5]. The symptoms of sepsis 
are polymorphic and depend on many factors: The 
age of the child, its premorbid state, the infectious 
agent, the source of infection, and others. At present, 
sepsis is considered as a body regulation disorder 
of the normal protective response to infection and 
a serious role in its development is given to genetic 
factors [6], [7], [8], [9]. Thus, at this stage, it is difficult 
to predict whether a particular child will have an 
infectious disease with sepsis or not, and clinical 
polymorphism and the presence of the so-called 
“latent” course of sepsis create significant diagnostic 
difficulties. On the other hand, timely diagnosis of 
sepsis in children and, consequently, the earliest 
possible start of therapy is crucial for the prognosis of 
the disease. Delay of therapy even for 1 h leads to an 
increase in mortality [5], [10].
In accordance with the foregoing, the earliest 
possible diagnosis of the septic process in children 
is one of the main tasks for the clinician. Indeed, the 
sooner targeted treatment is started, which includes 
antibiotics and infusion therapy, the more chances 
there are to stop the development of sepsis [11].
It should be noted that in this article we 
did not aim to consider the features of sepsis in 
newborns since sepsis in this age group differs 
significantly from sepsis in children older than the 
neonatal period and adults and requires separate 
consideration [12].
Research Materials and Methods
Study of the literary sources collected in the 
databases of PubMed, ScienceDirect, Cochrane 
Library, and search depth 10 years, from 2009 to 2019 
was conducted, all types of articles were studied, key 
words: Sepsis in children, pediatric sepsis, septic shock 
in children, sepsis diagnostics, sepsis recognition, and 
sepsis biomarkers. As a result of a thorough scientific 
search, 62 articles were selected that, in our opinion, 
are of the greatest interest according to the chosen 
topic.
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Main Part
Epidemiology of sepsis
Assessing the global epidemiology of sepsis 
and septic shock in children presents certain difficulties 
related to economic and diagnostic factors. In recent 
years, several attempts have been made to estimate 
the worldwide incidence of pediatric sepsis. In 2014, 
the original study the sepsis prevalence, outcomes and 
therapies study was published, showing very interesting 
results. The study included 6925 children from 128 
intensive care units (ICUs) from North America, Europe, 
Asia, Australia and New Zealand, South America, and 
Africa. The average incidence of severe sepsis was 
8.2%, but it certainly varied from 6.2% in Europe to 
23.1% in Africa. At the same time, the mortality rate 
from this pathology in all the studied countries was 
approximately the same and amounted to 23–24%. It is 
also interesting that the majority of patients (77%) were 
diagnosed with concomitant diseases, among which 
the most common were respiratory disorders. The most 
common foci of infection were the respiratory system 
(40%) and blood flow (19%) [1], [13], [14], [15].
A detailed review of 2019 showed the following 
results: In countries with a high level of economic 
development, the prevalence of severe sepsis ranged 
widely from 1.4% in Japan to 7.7% in the United States, 
the mortality rate from severe sepsis was 7–17%, 
from septic shock to 51%. In developing countries, 
the incidence of severe sepsis among children also 
varied from 1% to 25.9%, and the mortality rate was 
12.3–34.6%. The authors attribute these significant 
fluctuations to various diagnostic criteria and economic 
factors [16], [17].
At present, there are no clear and unambiguous 
criteria for diagnosing sepsis in children in the Republic 
of Kazakhstan. The statistical collection of population 
health of the Republic of Kazakhstan contains the 
following data: The incidence of sepsis in children under 
1 year was 7 children out of 1000 in 2016, 21 children 
out of 1000 in 2017, and the death rate from sepsis 
was registered only for neonatal sepsis and amounted 
to 3.88 per 10,000 children born alive [18].
It should also be noted that, according to 
research, most cases of sepsis occur before the age 
of 3 years, which can probably be associated with 
the anatomical and physiological characteristics of 
young children [11], [19], [20]. Children with chronic 
comorbidities had a higher mortality rate [21], [22].
Etiology of sepsis
Infectious agents that lead to septic 
complications in children differ from those in adults. 
Bacteria and viruses most often cause sepsis. For 
children older than the neonatal age is the most 
common causative agents are Streptococcus, 
Staphylococcus, Meningococcus, and Pseudomonas. 
Streptococcus pneumoniae most often leads to sepsis 
among toddlers and young children. It should also be 
noted the important role of Haemophilus influenzae in 
the development of sepsis in countries where there is 
no active vaccination against this infection. A special 
place is occupied by nosocomial and multi-resistant to 
antibacterial drugs microorganisms. Among hospital 
infections, Gram-negative bacteria – Pseudomonas 
aeruginosa, Klebsiella species, E. coli, Acinetobacter 
species, and Salmonella spp. – most often lead to 
sepsis. Catheter-associated sepsis is caused by 
coagulase-negative staphylococci [6], [19], [20], [23].
It is necessary to take into account the 
possibility of participation of other microorganisms in the 
development of sepsis – viruses and fungi. According 
to the literature, the prevalence of viral and mycotic 
septic complications in the child population is 2.9–
5.3%. Among viral infections, influenza, parainfluenza, 
adenovirus infection, CMV infection, and herpes are 
most often complicated by sepsis [24], [25].
Fungal infections usually lead to septic 
complications in children with concomitant 
immunodeficiency and the need for invasive 
manipulations. Among the pathogens of mycosis, 
sepsis is most often caused by Candida species, 
Candida albicans, and Aspergillus species.
In patients with immunodeficiency disorders 
of various etiologies, sepsis may be caused by 
opportunistic microorganisms [25].
It should be noted that it is not always possible 
to identify the pathogen in the hemoculture. According 
to current data, the pathogen remains unknown in 
30–75% of children with sepsis [25], [26].
Definitions of sepsis and septic shock in 
children
The active study of sepsis and its complications 
continues all over the world, and new data on 
pathophysiology, microbiology, and clinical disciplines 
are accumulating, which contributes to changing the 
current understanding of this condition. If earlier the 
leading role in the development of sepsis was given 
to an infectious agent, then gradually the pathological 
reaction of the macroorganism came to the fore, that 
is, a generalized inflammatory response combined with 
damage to various organs and systems. Thus, there 
was a fundamentally new understanding of sepsis, 
approaches to its diagnosis and treatment.
According to the original concept of the 
American College Consensus Conference of 
pulmonologists and Society of Critical Care Medicine 
ACCP/Society Critical Care Medicine (SCCM), 1991, 
basis of sepsis development was considered to be 
systemic inflammatory reaction syndrome in response 
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to infectious aggression. To diagnose sepsis, the 
criteria for systemic inflammatory response syndrome 
(SIRS) were developed, which clinicians have relied 
on for a long time in their work. However, it has now 
been established that the response of the human body 
to a microbial agent is a much more complex and multi-
faceted process in which not only the immune system 
but also other organ systems are actively involved, 
as well as genetic characteristics, gender, age, race, 
concomitant conditions, and therapy [9], [27], [28], [29]. 
Due to these factors, the clinical picture of sepsis is 
characterized by pronounced polymorphism, which 
makes it very difficult to diagnose it early.
It should also be noted that the results of the 
conducted studies indicate a low specificity of SIRS 
criteria in the diagnosis of sepsis. SIRS develops in 
most patients of the ICU against a variety of conditions 
and, in principle, does not indicate the etiology of the 
disease. In addition, the existence of SIRS-negative 
sepsis has now been proven. In this case, sepsis 
develops without prior development of systemic 
inflammation, respectively, according to the ACCP/
SCCM criteria, such children cannot be classified as 
patients with sepsis [30].
Thus, on the one hand, the concept of sepsis 
ACCP/SCCM was an important step toward studying 
the problem of sepsis and set a further direction for the 
search, on the other hand, it left a lot of questions.
In 2005, the results of the International Pediatric 
Sepsis Consensus Conference (IPSCC-2005) were 
published. Criteria for SIRS and definition of sepsis in 
children were developed based on criteria for adults, 
taking into account the anatomical and physiological 
characteristics of children of different age groups [31].
In 2016, new consensus definitions of sepsis 
and septic shock were published, called “The Third 
International Consensus on the definition of sepsis and 
septic shock “(Sepsis-3”),” authored by experts from 
the SCCM, European Society Intensive Care Medicine. 
According to new data, sepsis is considered as a 
dysregulation of the body response to the infectious 
process with the development of organ dysfunction. 
At the same time, the concept does not deny the 
participation of systemic inflammation in the septic 
process, but considers it as one of the possible variants 
of the body response to infection [9].
Modern diagnostics of sepsis and septic 
shock in children
There are several fundamentally important 
differences in the development of the body response 
to infection, which clearly distinguish between pediatric 
sepsis and adult sepsis. Age-related differences in 
the concentration and composition of hemoglobin, 
heart rate, stroke volume, blood pressure, pulmonary 
vascular resistance, systemic vascular resistance, 
metabolic rate, glycogen stores, and protein mass are 
the basis of many age-related differences in the body 
response to infection [32], [33], [34], [35]. Thus, the 
principles of sepsis diagnosis developed for adults are 
not suitable for children.
Modern diagnostics of sepsis, as well as its 
complications – septic shock and multiple organ failure 
– in children are based on the recommendations of 
IPSCC-2005 and “Sepsis-3” (Tables 1 and 2). Diagnostic 
measures can be divided into two groups: Clinical 
diagnostics and laboratory-instrumental methods. 
Despite the large number of different laboratory markers 
of systemic inflammation and sepsis, most researchers 
now agree that the priority belongs to clinical signs. 
This can be attributed to the lack of a universal marker 
that would be sensitive to all types of infection, detect 
sepsis, at the earliest stages, in different children 
and would be financially available in any clinic in the 
world. As mentioned above, sepsis is a condition 
characterized by clinical polymorphism, but it has certain 
pathophysiological stages of development that can be 
traced in the patient’s condition.
In accordance with the concept of IPSCC-
2005, sepsis begins with a systemic inflammatory 
reaction, for the diagnosis of which certain criteria were 
proposed, adapted to children of different age groups.
Age groups of children with sepsis, IPSCC- 
2005 [31] (Table 3)
1. Early neonatal period (0–7 days)
2. Late neonatal period (8–28 days)
3. Infant age (29 days–1 year)
4. Preschool age (1–5 years)
5. School age (6–12 years)
6. Adolescence (13–18 years).
Systemic inflammation develops not only as a 
result of infection but also in other conditions (injuries, 
acute pancreatitis, in the postoperative period, etc.) 
since it is essentially a non-specific reaction of the body 
to damage [36], [37]. This reduces its diagnostic value in 
sepsis. In accordance with the concept “Sepsis-3”, the 
main manifestation of sepsis is organ dysfunction, which is 
recommended to determine in the ICU using the Pediatric 
Sequential Organic Failure Score (pSOFA) (Table 4).
The advantages of the scale include high 
specificity and sensitivity in relation to children in the ICU 
[38]. On the other hand, the scale is aimed at predicting 
the outcome of the disease, rather than diagnosing sepsis 
at the early stages of its development, when there are no 
pronounced signs of multiple organ failure; in addition, 
the scale requires daily biochemical studies, which is 
not always possible and not always safe for the patient, 
especially for young children. Thus, the search for a better 
tool for timely diagnosis of sepsis continues [39], [40].
At the same time, there is no doubt that the 
concept of multiple organ failure as a leading link in 
pathogenesis is an important step toward improving the 
management of sepsis in children and adults.
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Septic shock in children
Septic shock in a child is considered as severe 
hemodynamic disorders that complicate the course of 
sepsis. It should be noted that the clinical manifestations 
of septic shock in children differ from those in adults due 
to age-related features of the circulatory system. It is 
important to remember that arterial hypotension in children 
of the 1st year of life appears only at the later stages of 
shock development. Focusing only on blood pressure, 
the doctor risks missing the development of septic shock. 
It is known that the main compensatory mechanism of 
hemodynamics in young children is an increase in heart 
rate, so tachycardia is one of the most significant signs 
in shock in a young child. Pathogenetic mechanisms of 
septic shock lead to a disorder of microhemodynamics, 
which can be seen clinically by evaluating the time of 
capillary filling. Disorder of microhemodynamics leads 
to tissue hypoxia, which manifests itself as a significant 
increase in the concentration of lactate in the blood 
plasma. Thus, the main signs indicating septic shock in 
a child should not be considered a decrease in blood 
pressure, but signs of impaired tissue perfusion and 
tachycardia – as an attempt by the body to compensate 
for hemodynamic disorders [31], [41].
Criteria for cardiovascular dysfunction (after 
infusion of at least 40 ml/kg), IPSCC-2005 [31]
• Arterial hypotension – decreased systolic 
pressure <2 SD or the need to use 
vasopressors, or 2 criteria
• Unexplained metabolic acidosis with base 
deficiency >5 mEq/L
• Lactate acidosis: Serum lactate >2 norms
• Oliguria (<0.5 ml/kg/h)
• Symptom of a “white spot” (a spot that appears 
when pressing your finger on the skin over the 
III-IV metatarsal bones of the patient lying on 
his back) >5 s
• Difference between central and peripheral 
temperature >3°C.
Specific diagnosis of sepsis and septic 
shock in children
Numerous laboratory biomarkers are used 
to clarify the diagnosis of sepsis and septic shock. 
Seroreactive protein (CRP) and procalcitonin (PCT) 
are the most commonly used in clinical practice. CRP 
is recommended to be used in combination with PCT; 
together they have shown high efficiency in recognizing 
severe bacterial infection in young children with long-
term fever, as well as in neutropenia. Isolated use of 
CRP is not recommended [42].
According to research, PCT is a valuable 
diagnostic marker for sepsis caused by bacterial 
infection in children. It should be noted that the 
concentration of PCT may increase in non-infectious 
conditions, which limits its use [43].
Presepsin is an effective biochemical marker 
of sepsis, the mechanism of which is different from the 
mechanism of increasing CRP, PCT, and other markers. 
The level of presepsin increases quickly when the 
infection generalizes and also quickly shows a positive 
trend. According to a recent meta-analysis, presepsin 
showed high sensitivity and diagnostic accuracy in 
sepsis in children compared to CRP and PCT, but 
its specificity was lower. There was also a significant 
increase in presepsin concentration in children 
with suspected or registered catheter-associated 
infection compared to healthy children in the control 
group [44], [45], [46].
Table 2: Definitions of sepsis according to the concept 
“Sepsis-3” [9]
Definition Sepsis is a life-threatening acute organ dysfunction that occurs 
as a result of a disorder of the regulation of the macroorganisms 
response to infection
Pathophysiological 
diagnostics
Disorder of the regulation of the macroorganisms response to 
infection is manifested by damage to its own tissues and organs
Criteria of sepsis Suspected or documented infection in combination with acute organ 
dysfunction, the development of which is concluded on the index of 
the SOFA scale by 2 points or more from the base value
Septic shock A clinical variant of the course of sepsis characterized by circulatory 
insufficiency, which is manifested by arterial hypotension, an 
increase in the level of lactate more than 2 mmol/l, despite 
adequate infusion, and requiring the administration of vasopressors 
to maintain normal blood pressure
The level of cytokines in the blood increases 
early in the infectious process, which allows them 
to be used as markers of systemic inflammation 
and sepsis. According to different authors, the 
concentration of IL-6 in serum in children with sepsis 
Table 3: Systemic inflammatory reaction syndrome in children, 
IPSCC-2005 [31]
Age Heart rate RR Leukocytes, 
*109/l
Systolic blood 
pressure, mm HgBradycardia Tachycardia
0 – 7 days < 100 > 180 > 50 > 34000 < 65
8 – 28 days < 100 > 180 > 40 > 19500 or 
 < 5000
< 75
28 days–1 year < 90 > 180 > 34 > 17500 or  
< 5000
< 100
1 – 5 years - > 140 > 22 > 15500 or 
 < 6000
< 94
6 – 12 years - > 130 > 18 > 13500 or 
 < 4500
< 105
13 – 18 years - > 110 > 14 > 11000 or  
< 4500
< 117
Table 1: Definitions of sepsis in children, IPSSC-2005 [31]
SIRS
•  The presence of at least two of the following four criteria, one of which is necessarily   
an abnormal temperature or number of white blood cells
• Central temperature > 38.5°C or < 36.0°C
•  Tachycardia defined as a heart rate exceeding 2 square deviations from the age norm 
in the absence of external stimuli; for children less than 1 year – bradycardia defined 
as a heart rate < 10% in the absence of external stimuli; or unexplained hemodynamic 
depression lasting more than half an hour
•  Respiration rate exceeding 2 square deviations from the age norm or the need for a 
ventilator in an acute process that is not associated with neuromuscular diseases or 
general anesthesia
•  The number of white blood cells increased or decreased in comparison with the age 
norm, in the absence of chemotherapy, or immature neutrophils >10%
Infection
•  Suspected or proven by detecting a pathogen in the internal environment, caused by 
any pathogen, or clinical syndromes associated with a high probability of infection
Sepsis
• SIRS in the presence of a proven or suspected infection
Severe sepsis
•  Sepsis + one of the following: Cardiovascular organ dysfunction, acute respiratory 
distress syndrome, and two or more dysfunctions of other organs and systems
Septic shock
• Sepsis + cardiovascular organ dysfunction
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differs significantly from its concentration in healthy 
children [25], [47].
Lactate is used to diagnose septic shock and 
evaluate its therapy, but evidence for its effectiveness 
in children is limited. Studies have shown that the 
concentration of lactate in blood plasma in children 
more than 4 mmol/l is associated with the development 
of multiple organ failure in the next 24 h, but in 4% 
of cases, multiple organ failure developed in children 
with a lactate level <4 mmol/l. Therefore, normal or 
slightly elevated levels of lactate in blood plasma do not 
exclude the development of severe sepsis and septic 
shock [48], [49].
Pentraxin 3 significantly increases in critically ill 
children, including those with sepsis, but there was no 
difference in the concentration of pentraxin 3 between 
critically ill children with sepsis and other diagnoses. 
Thus, pentraxin 3 is more of a marker of systemic 
inflammation than of sepsis [45].
In recent years, The Pediatric Sepsis Biomarker 
Risk Model (PERSEVERE, PERSEVERE II, and 
PERSEVERE-XP) biomarker panels based on patient 
genome studies have been developed to identify the 
risk of death in septic shock in children. PERSEVERE 
biomarkers are generally associated with inflammation 
and cellular damage, which makes it highly likely to 
identify the risk of deterioration in a particular child with 
septic shock [50], [51], [52].
There are also separate studies that 
prove the diagnostic effectiveness in pediatric 
sepsis of indicators of hemostasis, leuco formula, 
adapted to the age characteristics of the “shock 
index” [53], [54], [55], [56].
It should be noted that currently no set of 
biomarkers can reliably detect the presence of sepsis 
in a child, and PERSEVERE panels require special 
equipment and are aimed only at recognizing septic 
shock in ICU conditions, so the use of laboratory 
studies should always be based on the clinical 
picture [57], [58].
Conclusion
It should be noted that much has been done in 
the study of pediatric sepsis in recent years [59], [60]. 
In general, child mortality in the world has decreased 
significantly in recent years, including through the 
use of common methods of diagnosis and treatment 
confirmed by numerous studies [61]. The mainstreaming 
of modern diagnostic methods should significantly 
reduce the mortality from sepsis and its complications 
in children due to earlier and better recognition of this 
process.
Despite the undoubted success in the study 
of sepsis, there are still a number of urgent problems, 
especially typical for pediatrics. First, the SIRS cannot 
be the only basis for diagnosing sepsis. Second, 
diagnosis of sepsis using the pSOFA scale in children 
requires the presence of obvious organ dysfunction, 
which delays treatment. Third, the pSOFA scale, like 
other similar scales, was created to assess the severity 
of the patient’s condition and predict death, not to 
diagnose sepsis. The scale requires daily laboratory 
tests, which may not be available in real clinical settings 
and require frequent blood sampling, including in very 
young children.
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